Form 4 Tracker
Helen Torley

Director, PRESIDENT AND CEO · 8 filings · Latest: May 11, 2026

HALOZYME THERAPEUTICS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 20, 2026
Option Exercise
$0.0016,757766,488
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 16, 2026
Option Exercise
$0.0089,055777,336
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 5, 2026
Sale
$78.6410,000$786.4K708,719
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 5, 2026
Option Exercise
$12.0710,000$120.7K718,719
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 4, 2026
Sale
$77.2420,000$1.5M708,719
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 4, 2026
Option Exercise
$12.0720,000$241.4K728,719
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 3, 2026
Sale
$76.1220,000$1.5M708,719
HALO
Helen TorleyDirector, PRESIDENT AND CEOFeb 3, 2026
Option Exercise
$12.0720,000$241.4K728,719
HALO
Helen TorleyFeb 3, 2026
Proposed Sale
$74.45150,000$11.2M
HALO
Helen TorleyOct 1, 2025
Proposed Sale
$73.34136,569$10.0M
HALO
Helen TorleyJun 20, 2025
Proposed Sale
$53.15240,000$12.8M
HALO
HELEN TORLEYOct 9, 2024
Proposed Sale
$52.5810,000$525.8K
HALO
HELEN TORLEYOct 8, 2024
Proposed Sale
$54.0010,000$540.0K
HALO
HELEN TORLEYSep 26, 2024
Proposed Sale
$56.1010,000$561.0K
HALO
HELEN TORLEYSep 25, 2024
Proposed Sale
$56.3410,000$563.4K
HALO
HELEN TORLEYSep 24, 2024
Proposed Sale
$58.2110,000$582.1K
HALO
HELEN TORLEYSep 12, 2024
Proposed Sale
$59.2010,000$592.0K
HALO
HELEN TORLEYSep 11, 2024
Proposed Sale
$59.0910,000$590.9K
HALO
HELEN TORLEYSep 10, 2024
Proposed Sale
$59.0910,000$590.9K

← Previous

Page 2 of 2